Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells
暂无分享,去创建一个
[1] M. Lieber,et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.
[2] K. Tadokoro,et al. Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR , 2009, International journal of hematology.
[3] C. Jamieson,et al. Chronic myeloid leukemia stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] F. Michor. Chronic Myeloid Leukemia Blast Crisis Arises from Progenitors , 2007, Stem cells.
[5] K. Anderson,et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia , 2005, Nature Medicine.
[6] K. Motoyoshi,et al. Efficacy of low-dose imatinib in chronic-phase chronic myelogenous leukemia patients , 2008, Annals of Hematology.
[7] C. Jamieson. Chronic myeloid leukemia stem cells. , 2008, Hematology. American Society of Hematology. Education Program.
[8] B. Druker,et al. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy , 2002, Leukemia.